Humacyte Inc (HUMA) Company Profile & Statistics

Humacyte Inc
HUMA
(Nasdaq - US)
Closed
4.48
+0.10 (+2.28%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
4.39
High
4.52
Low
4.34

About Humacyte Inc

CEO

Laura E. Niklason

Headquarters

2525 east north carolina highway 54

durham, nc 27713, united states

Auditor

PricewaterhouseCoopers LLP

Employees

185

Share Holders

195

Website

www.humacyte.com

Industry

biotechnology

Sector

health technology

Company Overview

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

Humacyte Inc Statistics

Valuation Measures

Market Capitalization ²	563.85M
Enterprise Value	560.49M
Enterprise Value/EBITDA (ttm)	-5.32
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-942.81%
Return on Invested Capital (ttm)	349.81%
Return on Assets (ttm)	-93.82%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-105.28M
Net Income Avi to Common (ttm)	-152.87M
Diluted EPS (ttm)	-1.34

Share Statistics

Beta (5Y Monthly)	1.47
52-Week Change	74.32%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	125.86M
Dividend Yield	0.00%
Float ⁴	111.76M
% Held by Insiders	11.20%
% Held by Institutions	44.71%

Balance Sheet

Total Cash (mrq)	20.57M
Total Cash Per Share (mrq)	0.16
Total Debt (mrq)	17.21M
Total Debt/Equity (mrq)	-27.01%
Current Ratio (mrq)	1.10%
Quick Ratio (mrq)	1.10%
Book Value Per Share (mrq)	-0.53

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.60
Free Cash Flow (ytd)	-73.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Humacyte Inc

Trade With A Regulated Broker